Indeed, the angiogenesis biomarkers VEGF and Ang2 (angiogenin, ribonuclease A family, member 2) were independent predictors of advanced HCC patient survival (Llovet et al., 2012). Here, VEGFA is linked to hepatocellular carcinoma.